Although it is reported SARS-CoV-2 cell entry is blocked by clinically proven inhibitors of ACE2 and TMPRSS2 [43], but identification of new targets is very necessary to curb the infection or mortality caused by SARS-CoV-2. The gene discussed is ACE2; the disease is infection.